Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

14.35 -0.28 (-1.91%)
Streaming Delayed Price Updated: 11:25 AM EST, Jan 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,096,039
Open 14.38
Bid (Size) 14.34 (300)
Ask (Size) 14.36 (300)
Prev. Close 14.63
Today's Range 13.86 - 14.57
52wk Range 5.900 - 28.25
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Stocks
News headline image
Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October. 
Via Stocktwits
Topics Artificial Intelligence ETFs

Performance

YTD
+55.8%
+55.8%
1 Month
+52.0%
+52.0%
3 Month
-3.0%
-3.0%
6 Month
+9.5%
+9.5%
1 Year
+36.0%
+36.0%

More News

Read More
News headline image
Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗
Via The Motley Fool
Topics Death
News headline image
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗
Via Investor's Business Daily
News headline image
Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
Via FinancialNewsMedia
News headline image
2 Beaten-Down Stocks to Avoid Right Now ↗
Via The Motley Fool
Topics Death
News headline image
This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗
Via Benzinga
News headline image
This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗
Via Benzinga
News headline image
What 21 Analyst Ratings Have To Say About Intellia Therapeutics ↗
Via Benzinga
News headline image
Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
Via Investor's Business Daily
Topics Death
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗
Via Investor's Business Daily
Topics Death
News headline image
2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street ↗
Via The Motley Fool
News headline image
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials ↗
Via Chartmill
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130% ↗
Via The Motley Fool
Topics Death
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?
Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?
The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market
What is the current price of Intellia Therapeutics, Inc. - Common Stock?
The current price of Intellia Therapeutics, Inc. - Common Stock is 14.35
When was Intellia Therapeutics, Inc. - Common Stock last traded?
The last trade of Intellia Therapeutics, Inc. - Common Stock was at 01/26/26 11:25 AM ET
What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?
The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.26B
How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?
Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.